
The editor in chief of Evidence-Based Oncology calls for universal biomarker testing in every patient, the same standard set for patients in his practice.

Sucharu "Chris" Prakash, MD, is the director of quality services, chair of medical oncology quality, and medical director at Texas Oncology.

The editor in chief of Evidence-Based Oncology calls for universal biomarker testing in every patient, the same standard set for patients in his practice.

Texas Oncology boosts precision medicine with near-universal biomarker testing, quality measurement, and genomic insights—advancing health equity through streamlined workflows and coverage. This commentary will appear in the June issue of Evidence-Based Oncology.

EBO Editor in Chief Sucharu "Chris" Prakash, MD, addresses the role of nutrition in cancer prevention and treatment.

The editor in chief of Evidence-Based Oncology lauds Congress' authorization of a path for Medicare coverage for multicancer early detection.


Consolidation in oncology is creating access and cost challenges, whereas advocacy helps improve patient care and treatment availability, according to Sucharu "Chris" Prakash, MD.

April 16th 2026